News | Cardiovascular Clinical Studies | July 22, 2020

Eating Chocolate Once a Week May Reduce Risk of Heart Disease

New study shows evidence chocolate is good for the heart

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell


July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to research published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).[1] 

“Our study suggests that chocolate helps keep the heart’s blood vessels healthy,” said study author Chayakrit Krittanawong, M.D., of Baylor College of Medicine, Houston, Texas.

“In the past, clinical studies have shown that chocolate is beneficial for both blood pressure and the lining of blood vessels,” he continued. “I wanted to see if it affects the blood vessels supplying the heart (the coronary arteries) or not. And if it does, is it beneficial or harmful?”

The researchers conducted a combined analysis of studies from the past five decades examining the association between chocolate consumption and coronary artery disease (the blockage of the coronary arteries). The analysis included six studies with a total of 336,289 participants who reported their chocolate consumption.

During a median follow-up of nearly nine years, 14,043 participants developed coronary artery disease and 4,667 had a heart attack (when coronary artery disease progresses and the flow of blood to the heart is suddenly blocked).

Compared with consuming chocolate less than once a week, eating chocolate more than once a week was associated with an 8 percent decreased risk of coronary artery disease.

“Chocolate contains heart healthy nutrients such as flavonoids, methylxanthines, polyphenols and stearic acid which may reduce inflammation and increase good cholesterol (high-density lipoprotein or HDL cholesterol),” Krittanawong said.

He noted that the study did not examine whether any particular type of chocolate is more beneficial and whether there is an ideal portion size. “Chocolate appears promising for prevention of coronary artery disease, but more research is needed to pinpoint how much and what kind of chocolate could be recommended,” he said.

While it is not clear how much chocolate is optimal, Krittanawong warned against overeating. “Moderate  amounts of chocolate seem to protect the coronary arteries but it’s likely that large quantities do not. The calories, sugar, milk, and fat in commercially available products need to be considered, particularly in diabetics and obese people,” he explained.

 

Related Content of Chocolate and Heart Health:

Swedish Study Shows Chocolate May Prevent Stroke

Moderate Chocolate Consumption Linked to Lower Heart Failure Risk

New Study Finds Eating Chocolate Regularly Could Cut Cardiovascular Risk by One Third

Cocoa, Chocolate May Repair Blood Vessels, Increase Blood Flow

Dark Chocolate May Help Lower Risk of Heart Attack

Editor’s Choice for Most Innovative Technology at ACC 2012

Regular Caffeine Consumption Does Not Result in Extra Heartbeats

 

Reference:

1. Krittanawong C, Narasimhan B, Wang Z, et al. Association between chocolate consumption and risk of coronary artery disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2020. doi:10.1177/2047487320936787.

 

Related Content

News | Cardiovascular Clinical Studies

June 24, 2022 — Henry Ford Health was part of a multi-institutional heart failure study that was launched and executed ...

Home June 24, 2022
Home
News | Cardiovascular Clinical Studies

June 21, 2022 — Renibus Therapeutics (“Renibus”), a clinical-stage biotech company focusing on the prevention and ...

Home June 21, 2022
Home
News | Cardiovascular Clinical Studies

June 13, 2022 — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that ...

Home June 13, 2022
Home
News | Cardiovascular Clinical Studies

June 1, 2022 — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced that its ...

Home June 01, 2022
Home
News | Cardiovascular Clinical Studies

May 31, 2022 — Findings from the XARELTO (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and ...

Home May 31, 2022
Home
News | Cardiovascular Clinical Studies

May 26, 2022 — For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol ...

Home May 26, 2022
Home
News | Cardiovascular Clinical Studies

May 25, 2022 — Researchers from the group of Eva van Rooij used advanced sequencing technology to better understand the ...

Home May 25, 2022
Home
News | Cardiovascular Clinical Studies

May 23, 2022 — A specific protein in blood vessel cells plays a major role in the development of vascular and ...

Home May 23, 2022
Home
News | Cardiovascular Clinical Studies

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...

Home May 20, 2022
Home
News | Cardiovascular Clinical Studies

May 11, 2022 — Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a ...

Home May 11, 2022
Home
Subscribe Now